Darren Hauck/Getty Images
Associate research specialist at the Wisconsin National Primate Research Center at University Wisconsin-Madison removes a new batch of Embryonic Stem Cells from deep freeze to be thawed before being worked on.
Today – biotech company Geron announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells. The company will be injecting the cells directly onto injured spinal cords with the hope that the cells will re-grow damaged connections and help paralyzed patients regain at least some movement. Where does congress stand on stem cells today and what does that mean for Geron?
Alan Trounson, President of the California Institute of Regenerative Medicine